Gene variants associated with cancer risk appear to contribute to carcinogenesis by regulating target genes that in turn promote the generation of mutations.
News: August, 2019
Colorectal cancer researchers from Vanderbilt-Ingram Cancer Center (VICC) have been awarded a Specialized Program of Research Excellence grant from the National Cancer Institute (NCI).
Breast cancer researchers at Vanderbilt-Ingram Cancer Center have secured a fourth round of continuous Specialized Program of Research Excellence funding.
Combining immunotherapy and radiation therapy may be a powerful treatment approach for castration-resistant prostate cancer.
Jason MacGurn and colleagues have characterized a “rheostat” that sets WNT pathway signaling in breast cancer cells.
Inflammation synergizes with a cell’s intrinsic genetic program to promote the development of pancreatic cancer.
Investigators are exploring the molecular mechanisms behind the association of chronic inflammation and colon cancer.
A study led by Anna Vilgelm, MD, PhD, and Ann Richmond, PhD, has identified a possible second-line treatment for melanoma patients.
A previously unrecognized role for a cell surface receptor may open new therapeutic options for the treatment of fibrotic diseases.
Younger patients say colorectal cancer is a disease that doesn’t follow age guidelines, so pay attention to early symptoms.